continue increasing competition by introducing oral GLP-1, dual incretin and novel metabolic drugs
Peptides That Help with Weight Loss Semaglutide: Mimics the GLP-1 hormone, effectively reducing appetite and promoting weight loss
Association of urinary oxalate excretion with the risk of chronic kidney disease progression
Introduction# CagriSema (cagrilintide + semaglutide, Novo Nordisk) and tirzepatide (Eli Lilly) represent the pinnacle of next-generation obesity pharmacotherapy, both achieving approximately 20% weight loss through different dual-mechanism approaches
At normal blood glucose levels, up to 97% of glucose filtered by the glomeruli is reabsorbed by sodium-dependent glucose transporter-2 (SGLT2) in the initial segment of the tubule, and only 3% of the remaining glucose is reabsorbed by sodium-dependent glucose transporter-1 (SGLT1) in the later segment of the proximal tubule ( In summary, hyperglycemia induces renal tubules metabolic disturbances, hypoxia, oxidative stress, EMT, and programmed cell death which facilitate renal tubular injury and renal fibrogenesis
B., Xia, Z., Lofton, H., Huang, S
